Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21 CIP1/WAF1

Journal of Cellular Physiology

Volumn 205, Issue 1, 2005, Pages 107-113

  Lim, Do Y ^a   Tyner, Angela L ^b   Park, Jae Bong ^c   Lee, Jae Yong ^c   Choi, Yung H ^d   Park, Jung H Y ^a  

^a Hallym University   (South Korea)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Hallym University College of Medicine   (South Korea)

^d Dong Eui University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; NATURAL PRODUCT; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; ENZYME INHIBITION; FLOW CYTOMETRY; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; WILD TYPE;

CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DIET; HUMANS; LINOLEIC ACIDS, CONJUGATED; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 24344450669     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20380     Document Type: Article

References (42)

1. Belury MA. 2002. Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action. J Nutr 132(10):2995-2998.
2. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ. 1997. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med 3(11):1233-1241.
3. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, Lee HS, Tyner AL, Park JH. 2003. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284(6): G996-G1005.
4. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kanzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75(4):817-825.
5. Cartel AL, Tyner AL. 1999. Transcriptional regulation of the p21(WAF1/CIP1) gene. Exp Cell Res 246(2):280-289.
6. Cartel AL, Tyner AL. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1(8):639-649.
7. Gobert C, Skladanowski A, Larsen AK. 1999. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc Natl Acad Sci USA 96(18):10355-10360.
8. Coke R, Coke A, Coke B, El-Deiry WS, Chen Y. 2001. Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1. Digestion 64(2):75-80.
9. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4):805-816.
10. Herbel BK, McGuire MK, McGuire MA, Shute TD. 1998. Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin Nutr 67(2):332-337.
11. Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A, Crispe IN. 2000. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip1/WAF-1, which promotes apoptosis. J Immunol 164(8):4032-4036.
12. Ikeda MA, Jakoi L, Nevins JR. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci USA 93(8):3215-3220.
13. Kadowaki Y, Fujiwara T, Fukazawa T, Shao J, Yasuda T, Itoshima T, Kagawa S, Hudson LG, Roth JA, Tanaka N. 1999. Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer. Clin Cancer Res 5(12):4233-4241.
14. Kang KH, Kim WH, Choi KH. 1999. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res 253(2):403-412.
15. Kemp MQ, Jeffy BD, Romagnolo DF. 2003. Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: Effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr 133(11):3670-3677.
16. Kim EJ, Kim WY, Kang YH, Ha YL, Bach L, Park JHY. 2000. Inhibition of Caco-2 cell proliferation by (n-3) fatty acids: Possible mediation by increased secretion of insulin-like growth factor binding protein-6. Nutr Res 20(10):1409-1421.
17. Kim EJ, Kang IJ, Cho HJ, Kim WK, Ha YL, Park JH. 2003. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J Nutr 133(8):2675-2681.
18. Kwon YH, Jovanovic A, Serfas MS, Tyner AL. 2003. The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury. J Biol Chem 278(32):30348-30355.
19. Lee MH, Reynisdottir I, Massague J. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9(6):639-649.
20. Lincet H, Poulain L, Remy JS, Deslandes E, Duigou F, Gauduchon P, Staedel C. 2000. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett 161(1): 17-26.
21. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD. 2002. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Faseb J 16(11):1447-1449.
22. Moberg K, Starz MA, Lees JA. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 16(4):1436-1449.
23. Nurse P. 2000. A long twentieth century of the cell cycle and beyond. Cell 100(1):71-78.
24. Obaya AJ, Sedivy JM. 2002. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 59(1):126-142.
25. Ohtani K. 1999. Implication of transcription factor E2F in regulation of DNA replication. Front Biosci 4:D793-D804.
26. Pardee AB. 1989. G1 events and regulation of cell proliferation: Science 246(4930):603-608.
27. Park HS, Ryu JH, Ha YL, Park JHY. 2001. Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazine-treated rats: A possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 86:549-555.
28. Park HS, Cho HY, Ha YL, Park JH. 2004. Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem 15(4):229-235.
29. Poole AJ, Heap D, Carroll RE, Tyner AL. 2004. Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23(49):8128-8134.
30. Saha D, Roman C, Beauchamp RD. 2002. New strategies for colorectal cancer prevention and treatment. World J Surg 26(7):762-766.
31. Sheikh MS, Rochefort H, Garcia M. 1995. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11(9):1899-1905.
32. Sherr GJ. 1994. G1 phase progression: Cycling on cue. Cell 79(4):551-555.
33. Sherr CJ. 1996. Cancer cell cycles. Science 274(5293):1672-1677.
34. Taya Y. 1997. RB kinases and RB-binding proteins: New points of view. Trends Biochem Sci 22(1):14-17.
35. Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL. 1999. Adenovirus-mediated p21(WAF1/SDII/CIP1) gene transfer, induces apoptosis of human cervical cancer cell lines. J Virol 73(6):4983-4990.
36. Tsurimoto T. 1999. PCNA binding proteins. Front Biosci 4:D849-D858.
37. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T. 2002. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 98(4):498-504.
38. Waga S, Hannon GJ, Beach D, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369(6481):574-578.
39. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81(3): 323-330.
40. Xiong Y, Hannon, GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366(6456):701-704.
41. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, Yang K, Augenlicht LH. 2001. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 61(2):565-569.
42. Zhang H, Xiong Y, Beach D. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4(9):897-906.